High failure rate of transungal drug delivery: need for new strategies.

Nails are the toughest part of the human body. However, due to unabated exposure to environment stress and day-to-day chores, they are highly prone to infections. Onychomycosis is the fungal infection of the nail that can involve one or more of the nail unit components. Infection generally initiates from the distal portion of the toe or finger nail and later spreads to the proximal portion of the nail matrix. The whole width of the nail may be affected. Subsequently, it spreads proximally toward the posterior nail fold and medially to encompass the whole nail bed. In this process, nail can become grossly thickened, and may get completely destroyed [1].

[1]  Mayur M. Patel,et al.  Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis , 2016, Drug Delivery and Translational Research.

[2]  R. Neubert,et al.  Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[3]  H. Maibach,et al.  Transungual delivery of ketoconazole using novel lacquer formulation. , 2013, International journal of pharmaceutics.

[4]  L. Nogueiras-Nieto,et al.  Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  R. Beck,et al.  Antifungal Activity of Nanocapsule Suspensions Containing Tea Tree Oil on the Growth of Trichophyton rubrum , 2013, Mycopathologia.

[6]  F. Mailland,et al.  Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer. , 2010, Journal of drugs in dermatology : JDD.

[7]  D. Monti,et al.  Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity , 2010, The British journal of dermatology.

[8]  D. Monti,et al.  In Vitro Transungual Permeation of Ciclopirox from a Hydroxypropyl Chitosan-Based, Water-Soluble Nail Lacquer , 2005, Drug development and industrial pharmacy.

[9]  M. Repka,et al.  Influence of human nail etching for the assessment of topical onychomycosis therapies. , 2004, International journal of pharmaceutics.

[10]  H. Maibach,et al.  Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane. , 2003, Journal of pharmaceutical sciences.

[11]  A. Gupta,et al.  Ciclopirox nail lacquer and podiatric practice. , 2000, Journal of the American Podiatric Medical Association.

[12]  Roberts Onychomycosis: current treatment and future challenges , 1999, The British journal of dermatology.

[13]  P. Doncker,et al.  NAIL PENETRATION : FOCUS ON TOPICAL DELIVERY OF ANTIFUNGAL DRUGS FOR ONYCHOMYCOSIS TREATMENT , 1999 .

[14]  B. Lippold,et al.  In‐vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Penetration of Chloramphenicol from Lipophilic Vehicles and a Nail Lacquer , 1997, The Journal of pharmacy and pharmacology.

[15]  R. Summerbell Epidemiology and ecology of onychomycosis. , 1997, Dermatology.

[16]  G. Klecak,et al.  Loceryl® nail lacquer—realization of a new galenical approach to onychomycosis therapy , 1992, Clinical and experimental dermatology.